US Food and Drug Administration Launches AI Platform to ‘Modernize’ Agency – Decrypt

In brief

• The FDA launched Elsa, an AI platform that reduced one task from three days to six minutes.
• Elsa summarizes reports, compares drug labels, and identifies high-risk sites while keeping data secure.
• This marks the first of several AI initiatives as the FDA transforms its internal operations.